Links to New Drug Approval Announcements

[Guest guest]

Dear All,

Here are three new drug approvals:

1. U.S. advisory panel had recommended drug's use

* Afinitor seen as future blockbuster

ZURICH, May 6 (Reuters) - Novartis AG's (NOVN.VX) (NVS.N) cancer drug Afinitor

has been approved by the U.S. Food and Drug Administration for a rare type of

pancreatic cancer that has few treatment options.

http://www.reuters.com/article/2011/05/06/novartis-afinitor-idUSLDE74503Y2011050\

6

2. FDA Okays New Incretin Therapy for Diabetes

The FDA has approved another incretin therapy, linagliptin (Tradjenta), for

treatment of type 2 diabetes, the agency announced.

The dipeptidyl peptidase-4 (DPP-4) inhibitor is indicated in conjunction with

diet and exercise to control glycated hemoglobin levels in adults with the

disease, the FDA said.

http://www.medpagetoday.com/Endocrinology/Diabetes/26239

3. Docefrez (docetaxel) for injection, 20mg/vial and 80 mg/vial for locally

advanced or metastatic breast cancer, locally advanced or metastatic non-small

cell lung cancer and hormone refractory metastatic prostate cancer.

http://www.rttnews.com/Content/BreakingNews.aspx?Id=1614140 & SM=1